Intrapartum Monitoring Devices Market Size Worth $2.83 Billion By 2025

The global intrapartum monitoring devices market is expected to reach USD 2.83 billion by 2025, according to a new report by Grand View Research, Inc. The rising occurrences of preterm birth are resulting in increased infant mortality. The mortality rates differ across the globe, owing to the disparities of income, and lack of access to appropriate maternal care facilities in different regions. The regions with larger lower income groups face the highest infant mortality rates due to inadequate availability of obstetric monitoring and other infant care facilities. Effective maternal and postnatal care can help save more than 3 quarters of the premature babies.

According to the reports of WHO, annually 15.0 million infants are born premature. This number has been observed to be on a rise in the past few years. There are multiple causes for premature deliveries, such as high blood pressure, chronic conditions, infections, multiple pregnancies, early induction of labor. Hence, propelling the need for obstetric devices across the globe.

Rising awareness regarding availability of screening and monitoring procedures, growing prevalence of obesity & Gestational   Diabetes Mellitus (GDM) and increasing demand for improved intrapartum devices are expected to propel the market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/intrapartum-monitors-market

Further key findings from the study suggest:

  • The growing prevalence of obesity, rising preterm birth rate and increasing need for critical obstetric care is primarily driving the market growth
  • The electrodes dominated the market, owing to their affordability, higher adoption volume and repeat purchase.
  • The monitors segment is expected to exhibit fastest growth over the forecast period owing to the technological advancements.
  • North America dominated the market in 2016, owing to rising prevalence of obesity and diabetes, various government initiatives creating awareness regarding rising incidences of preterm births, availability of monitoring test options, and highly developed healthcare infrastructure.
  • Constant rise in the cases of preterm births and infant mortality rates are observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
  • The key players of the market include Analogic Corporation, GE Healthcare, Koninklijke Philips N.V.; Medtronic plc; CooperSurgical, Inc.; Stryker, and Olympus Corporation.
  • These players hold a strong position in market with their strategic initiatives such as mergers and acquisitions, partnerships with small/local players to expand their geographic foothold and widening of product portfolio by sharing the technology and products.

Microbiology & Bacterial Culture for Industrial Testing Market Worth $8.0 Billion By 2025

The global microbiology & bacterial culture for industrial (food, water, bioenergy) testing market size is expected to reach USD 8.0 billion by 2025, according to a new report by Grand View Research, Inc. Growing concern pertaining to the safety of feed supply provided to livestock is recognized as a high impact rendering factor for growth. The use of microorganisms for enhancing bioenergy reproducibility is expected to gain ground in the future microbiology & bacterial culture media & reagent market. This anticipated growth is attributed to the ongoing research and studies to enhance the application of microbial cell culture in biofuel production. 

In addition, growing knowledge pertaining to the significance of bacteria in agriculture and industrial applications is expected to positively influence the progress of the microbial cell culture market for agricultural research. Microbial testing to verify cleanliness or infestation of any pathogen in swab samples from a factory helps maintain the factory environment. Microbial tests, as verification of finished products, are required for product authorization. Microbiology food testing at various stages of development is found to serve as a high impact rendering driver.

In addition, various countries are establishing risk management strategies that include new quality control criteria as a preventive measure to curb the outbreak of microbial infection. These criteria incorporate sample checking in context to microbial parameters at various stages of production to maintain quality and safety. This is anticipated to directly translate into the growth in revenue for this market at a larger level.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/microbiology-culture-market

Further key findings from the report suggest:

  • Media is estimated to account for the largest revenue share due to the availability of ready-to-use and dehydrated media in customized forms
  • Higher adoption of bacteria in industrial production is attributed to the larger share of bacterial media
  • Bacterial media is anticipated to maintain its dominance over the forecast period as a consequence of higher usage in the industrial bioproduction
  • In 2016, food testing was the largest revenue grossing segment of the applications of microbiology culture media and reagents
  • Large application of these products for food and animal feed testing in order to ensure the quality of end product
  • Animal feed testing is anticipated to showcase lucrative growth over the study period due to escalation in the outbreak of animal diseases caused due to the consumption of contaminated feed
  • North American region holds a larger share in terms of revenue. A fair share can be credited to the innovative technology available for processing media and organisms required for bio-production
  • The industry in Asia Pacific is projected to exhibit potential progress in the coming years as a consequence of various developments across major economies, especially in the processed food industry
  • Lately, many multinational companies have shown huge interest in this region by investing heavily in setting up new facilities and promoting distributor networks to meet demand
  • Key players operating include Bio-Rad Laboratories, Inc., bioMérieux SA, Thermo Fisher Scientific, Inc., Merck KGaA, Neogen Corporation, HiMedia Laboratories, Eiken Chemical Co., Ltd.

Agriculture Equipment Market Size Worth $244.2 Billion By 2025

The global agriculture equipment market size is expected to reach USD 244.2 billion by 2025, expanding at a CAGR of 8.9% from 2019 to 2025, according to a study conducted by Grand View Research, Inc. Rising population has escalated demand for food and has pressurized the agriculture sector to be increasingly efficient and productive. Additionally, increased mechanization in the agriculture sector, rise in demand for agricultural products, and need for profitability and operational efficiency are some of the factors anticipated to drive the agricultural machinery market demand over the forecast period.

Rise in adoption of technology-driven equipment and machinery such as robotics is also anticipated to drive the farm machinery market demand over the forecast years. Farmers in developed regions are adopting modern technologies such as drones, moisture sensors, GPS enabled devices, self-driving tractors, smart irrigation, and terrain contour mapping to increase farm yield and address soaring food demand. Such technological advancements are fuelling the espousal of farm equipment across the globe.

The farm machinery market is also estimated to be driven by increasing sales in developing nations such as India, China, and Brazil, as these countries continue to mechanize their agricultural sectors. Furthermore, strong economic growth and population expansion are expected to impose pressure on the agriculture sectors to be more competent, thus increasing sales.On the down side, high cost of agricultural machinery and financial crisis faced by farmers are some of the major challenges hindering market growth.

The agriculture equipment market is highly competitive and fragmented owing to the presence of few prominent players, along with several medium- and small-scale players accounting for the market share. The key players in the market include John Deere, AGCO, Mahindra & Mahindra, CNH Industrial N.V., Iseki & Co., Ltd., and Kubota.

Several leading vendors are investing in R&D in order to develop innovative equipment and maintain a strong foothold in the market. For instance, in April 2017, Mahindra & Mahindra Limited launched its 24hp 4WD small tractor. It has been available in the Indian market since April 2017. The tractor caters to row cropping and horticulture applications, is capable of lifting up to 750 kg, and is equipped with automatic depth & draft control (ADDC) features.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/agriculture-equipment-market

  • The global agricultural equipment market is expected to register a CAGR of 8.9% from 2019 to 2025, due to technological advancements in agriculture automation and robotics as well as ever-increasing population
  • Growing number of government initiatives in developing countries, especially China and India, to enhance agricultural productivity is expected to further spur sale of farm equipment over the forecast period
  • By product, the tractors segment held the dominant share of over 25.0% in 2018, which is accredited to the fact that farmers are increasingly preferring tractors to increase production and restrict dependency on farm labor
  • On the basis of application, the harvesting and threshing segment is anticipated to witness significant growth over the forecast period and is expected to exceed a CAGR of 10.0% from 2019 to 2025
  • The Asia Pacific market is projected to expand at a CAGR of over 9.0%, owing to its existing and improving infrastructure levels, alternative sales channels, and government support
  • Key players in the market include John Deere, AGCO, Mahindra & Mahindra, CNH Industrial N.V., Iseki & Co., Ltd., and Kubota.

Unified Threat Management Market Size Worth $10.09 Billion By 2025

The global unified threat management market size is expected to reach USD 10.09 billion by 2025 at a CAGR of 14.5% from 2019 to 2025, according to a new study conducted by Grand View Research, Inc. Unified threat management (UTM) solutions eliminate the need for enhanced technical support and require fewer updates and contracts to manage network. This helps the end users to increase IT staff productivity and minimize operational costs. Latest trends, such as Bring-Your-Own-Device (BYOD), web applications, and virtualization, have compelled enterprises to prepare for emerging security risks in their networks, in addition to the growing concerns of internal and external threats. Growing number of such threats is impelling enterprises to adopt UTM solutions.

Moreover, these solutions are cost-effective and also have the ability to perform application-aware network tracking, scanning, and control. In addition, the solutions are easy to install & maintain and require lesser human intervention, which leads to further reduction in operational costs. All these factors are expected to drive the UTM market over the forecast period. Moreover, these solutions have multiple functionalities that allow consumers to reduce energy consumption and space. These benefits are further expected to contribute to the market growth. The key companies in the UTM market are focusing on developing advanced solutions that are aligned with the requirements of end users.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/unified-threat-management-utm-market

Further key findings from the study suggest:

  • Virtual component segment is anticipated to register the highest CAGR of 15.2% from 2019 to 2025 due to increasing number of SMEs requiring virtual infrastructure to securely run a wide range of applications
  • Managed UTM segment is anticipated to register significant growth over the forecast period as these solutions eliminate the need to buy multiple appliances for enterprises and offer complete network protection
  • The cloud segment is projected to expand at the highest CAGR during the estimated period. It is the most preferred deployment method of UTM solutions as it allows users to remotely manage the appliance
  • Large enterprise is projected to be the fastest-growing segment from 2019 to 2025 due to increasing adoption of UTM solutions, which are cost-effective and easy to install & maintain in large enterprises
  • BFSI segment is expected to register a significant growth in future. High demand for remotely managing security system, owing to increasing number of online hacks and cyberattacks in banks, is expected to drive the segment
  • North America is expected to continue to dominate the global UTM market over the forecast period owing to the presence of major companies in the region
  • Prominent industry participants include Barracuda Networks, Inc.; Cisco Systems, Inc.; Check Point Software Technologies Ltd.; SonicWall; Fortinet, Inc.; Huawei Technologies Co., Ltd.; Untangle, Inc.; Juniper Networks, Inc.; Sophos Ltd.; and WatchGuard Technologies, Inc.

Laser Processing Market Size Worth $23 Billion By 2025

The global laser processing market size is expected to reach USD 23 billion by 2025, at a CAGR of 8.9% according to a new report by Grand View Research, Inc. The rising utilization of expensive laser-drilling technique for oil & gas exploration purposes is projected to substitute the traditional techniques. Decreasing drilling costs are anticipated to increase the feasibility of uneconomic oil deposits; thus, positively impacting market growth. The growing need for this type of processing, in industrial solar modules, is further expected to fuel the market growth.

The requirement for laser technology in the medical sector is projected to witness a significant growth, owing to the increasing technological advancements. These technical developments offer faster recovery time, smaller incisions, and lesser pain. The increasing adoption of these methodologies is expected to spur the demand for surgical lasers. Advancements, leading to enhanced edge quality & cutting speeds, are anticipated to offer higher avenues to the laser processing market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/laser-processing-market

Further key findings from the report suggest:

  • Fiber lasers are projected to exhibit a significant growth with a CAGR exceeding 10.0% from 2016 to 2025, as they are widely used across several end-use industries and are highly cost-effective, compared to the other products
  • The material processing segment is expected to gain prominence over the forecast period with an estimated CAGR exceeding 9%, which can be accredited to the ability of lasers to perform high-speed & accurate industrial processes
  • The Asia Pacific region emerged as the fastest-growing region and is expected to witness a CAGR of over 10%, owing to the rising number of OEMs in this region
  • The key purveyors of this industry are Trumpf, Han’s Laser Technology Industry Group Co., Ltd., Amada Co., Ltd., and Rofin-Sinar Technologies, Inc., among others. Industry participants focus on technology advancements and innovation to capture market share.

Freeze Drying Equipment Market Size Worth $2.77 Billion By 2025

The global freeze drying equipment market size is anticipated to reach USD 2.77 billion by 2025, according to a study conducted by Grand View Research, Inc., progressing at a CAGR of 8.7% during the forecast period. Introduction of new injectable formulations and biologic drugs along with upswing in the demand for custom-built food industry have bolstered market growth. Furthermore, the market is also driven by expansion of the biotechnology industry and growing focus of pharmaceutical manufacturers on emerging markets.

Growing interest of biotechnology industry participants in freeze drying equipment in regions such as Asia Pacific and Latin America is projected to drive the market. Additionally, development of biosimilar and vaccines in developing regions and shift of various biopharmaceuticals manufacturing industries from developed to developing regions is poised to drive the market in these regions. Additionally, various key players are aiming towards marking their market presence by acquiring small scale equipment manufacturers present in developing countries to gain a competitive edge. This is also stoking the growth of the market.

Furthermore, mobile freeze dryers are poised to witness significant growth over the forecast period owing to their portability & ease of use. Additionally, these products maintain original structure & quality of products for prolonged duration. Thus, the market is likely to witness lucrative growth in the biotechnology sector due to increasing demand for storage of umbilical cords which are further used in surgeries. Moreover, food processing is expected to be one of the major application areas since freeze drying equipment preserve & extend shelf life and makes food products convenient to transfer.

However, higher set up & maintenance cost is estimated to hinder market growth. Increasing demand from various biotechnology and pharmaceutical companies for refurbished systems is anticipated to restraint market growth. Additionally, key players are engaged in introducing innovative products in the market to maintain their market presence and shares. Thus, introduction of new technologies and innovations is projected to boost the growth of the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/freeze-drying-equipment-market

Further key findings from the report suggest:

  • Mobile freeze dryers are likely to emerge as the fastest-growing segment over the forecast period owing to their efficiency of reducing moisture
  • The biotechnology industry is expected to be the most promising application segment during the forecast period. The growth of the segment can be attributed to benefits offered by the product such as reduced water fraction, high temperature tolerant, and product stabilization
  • Asia Pacific is estimated to register the highest CAGR of 11.5% over the forecast period owing to presence of various biotechnological & pharmaceutical industries in countries including India and China
  • The market is highly consolidated with presence of several well-established players. Key companies include Tofflon Science and Technology Co., Ltd, GEA Group, Labconco Corporation, and Azbil Corporation. Collaborations and mergers are key growth strategies undertaken by market players to sustain competition

Personalized Medicine Market Size Worth $3.18 Trillion By 2025

The global personalized medicine (PM) market size is expected to reach USD 3.18 trillion by 2025 registering a CAGR of 10.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing number of approved companion diagnostics and biomarker products have been proved promising avenues for the development of advanced precision diagnostic tests. Several personalized diagnostics and therapeutic products based on companion diagnostics are under clinical trials and development pipelines, which also add an incremental opportunity to accelerate this market.

Gene therapies are widely utilized to diagnose both chronic and genetic disorders according to individual’s genetic makeup. Growing adoption of gene sequencing and data analytics technologies is anticipated to escalate precision medicine market growth. Decreasing cost of whole genome sequencing, advancement in cell biology sector, and the development of “Human Genome Project” are several other factors influencing the demand for gene therapy hence, boosting the overall market. Moreover, key leaders are undergoing numerous strategic developments to launch novel personalized products, which will also contribute to the market expansion.

For instance, in September 2018, Vertex Pharmaceuticals collaborated with Genomics for the delivery of precision medicine based on individual’s genetic differences and lifestyle. Similarly, in January 2018, Foundation Medicine collaborated with European Organization for Research and Treatment of Cancer (EORTC) to facilitate Foundation’s comprehensive genomic profiling to across personalized medicine and clinical trial enrolment.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/personalized-medicine-market

Further key findings from the study suggest:

  • PM therapeutics is projected to register the fastest CAGR over the forecast period owing to the development of high-capacity rapid sequencing platforms for medical therapies
  • Reduction in sequencing cost leads to an expected growth of genomic sequencing and genetic research, thus contributing to lucrative opportunities for genomic medicine
  • Asia Pacific is projected to be the fastest-growing regional market due to rising number of collaborative initiatives between eastern and western market leaders
  • Chinese personalized medicine market is benefitted due to initiatives implemented by the Chinese government and reimbursements for disease treatment
  • Prominent companies include GE Healthcare; Illumina, Inc.; Asuragen, Inc.; Abbott Laboratories; Dako A/S; Exact Science Corp.; and Biogen, Inc.

Pharmacy automation devices market to grow at 7.3% CAGR in 2020

Pharmacy automation involves automation and mechanization of tasks that include distribution and handling medication processes carried out in heath care centers and specialty pharmacy centers. The global pharmacy automation devices industry is projected to grow at a CAGR of 7.3% from 2014 to 2020 and reach over USD 8.99 billion.

Automation systems such as packaging and labeling systems, medication dispensing system, storage and retrieval systems, table-top counters and compounding systems are employed in order improve the efficacy of regular jobs within pharmacies. The market is expected to grow owing to features including system integration that increases productivity and time to clinicians for patient care, thereby lowering medication errors.

Rising demand for pharmaceutical products, progressively growing technology and demand for precise robotic equipment & tools to perform operations at a faster rate are expected to be the key factors for market growth. Untapped growth opportunities in countries such as Brazil, China, and India coupled with escalating demand for automation in pharmacy and healthcare operations is expected to drive growth over the forecast period.

The market was dominated by automated medication dispensing systems in 2013. It accounted for a share of over 47.8% owing to growing demand for accurate medication dispensing systems. Automated dispensing systems have the ability to reduce significantly error rates and the ability to dispense hands-free. They provide storage, recording of medication, distribution to resident care and computer controlled dispensation.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/pharmacy-automation-market

Automated compounding systems are anticipated to grow rapidly at a CAGR of 8.4% from 2014 to 2020 owing to an increasing demand for mixing of medication and substantial decrease in total time to complete a dose.

The existence of IT healthcare systems and high rate of penetration in healthcare and pharmaceutical units resulted in North America occupying the largest regional market in 2013. It accounted for about 54.8% of the market revenue. Increasing healthcare overheads and R&D relevant to pharmacy automation devices are few factors responsible for its market share.

Asia Pacific is likely to grow at a CAGR of over 9.0% during the forecast period and is the most lucrative regional markets majorly due to improving healthcare infrastructure in emerging economies of China and India. Easy access available to new entrants including multinational pharmaceutical companies and distributors in this region coupled with the introduction of healthcare reforms in these countries is expected to drive market growth.

Key industry players include AmerisourceBergen Corporation, CareFusion Corporation, Accu-Chart Healthcare, ForHealth Technologies, GSE Scale Systems, Fulcrum Inc,McKesson Corporation, Innovation PharmaAssist Robotics, Pearson Medical Technologies, Health Robotics SRL, Kirby Lester, MedDispence, Pyxis Pharmacy Automation Systems, Medacist, MTS Medication Technologies, OmnicellInc, Cerner Corporation, Rice Lake Weighing Systems, Baxter International Inc., Aesynt Inc., ScriptPro LLC, Parat Systems Pharmacy Automation, Yuyama Co. Ltd, Swisslog Holding Ltd,Talyst Inc. and ScriptPro LLC.

Peripheral Vascular Devices Market Size Worth $8,918.8 Million By 2020

The global peripheral vascular devices market is expected to reach USD 8,918.8 million by 2020, growing at an estimated CAGR of 7.2% from 2014 to 2020, according to a new study by Grand View Research, Inc. Peripheral vascular devices such as IVC filters, angiography catheters, and plague modification devices are used for treating peripheral arterial or coronary arterial diseases caused due to the formation of atherosclerotic plaques in arteries. These devices are used to decrease the interference of patients with a minimum disturbance during the surgical procedure.

Increasing incidence of target diseases due to rising geriatric population, extensive presence of both private and public external funding programs, and changing lifestyle and eating habits are expected to be key driving factors for this market over the next six years. In addition, the presence of untapped growth opportunities in emerging markets such as India, Brazil, and China and increasing health awareness are also expected to serve this market as future growth opportunities.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/peripheral-vascular-devices-market

Further key findings from the study suggest:

  • Peripheral vascular stents dominated the peripheral vascular devices market in terms of share at over 30.8% in 2013; driven by increasing demand for drug-eluting and bio-absorbable stents. Moreover, the ability of these devices to significantly reduce restenosis rates is expected to boost product demand.
  • The embolic protection devices market is expected to grow at the fastest CAGR of 9.2% during the forecast period; owing to increasing demand for a minimally invasive endovascular surgical method for removing atherosclerosis from large blood vessels.
  • North America was the largest regional market in 2013, accounting for 40.3% of the global revenue. The presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and high R&D pertaining to drug discovery and development are some of the factors accounting for its large share.
  • Asia Pacific peripheral vascular devices market is expected to grow at the fastest CAGR of 10.0% from 2014 to 2020; primarily owing to the wide presence of unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China.
  • Key industry participants of this market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, W.L.Gore and Associates Ltd., and Angioscore Ltd.

Tissue Diagnostics Market Worth $6.6 Billion By 2027

The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

Click the link below:
https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market

Further key findings from the report suggest:

  • IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share
  • A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.
  • Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
  • A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer
  • Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease
  • Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures
  • North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
  • The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace
  • Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
  • Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.